SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001144204-18-011102
Filing Date
2018-02-27
Accepted
2018-02-27 12:28:27
Documents
10

Document Format Files

Seq Description Document Type Size
1 425 tv487192_425.htm 425 25721
2 GRAPHIC image_001.jpg GRAPHIC 21785
3 GRAPHIC image_002.jpg GRAPHIC 74321
4 GRAPHIC image_003.jpg GRAPHIC 93620
5 GRAPHIC image_004.jpg GRAPHIC 20338
6 GRAPHIC image_005.jpg GRAPHIC 86112
7 GRAPHIC image_006.jpg GRAPHIC 75623
8 GRAPHIC image_007.jpg GRAPHIC 8812
9 GRAPHIC image_008.jpg GRAPHIC 76741
10 GRAPHIC image_009.jpg GRAPHIC 72065
  Complete submission text file 0001144204-18-011102.txt   751287
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filed by) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Subject) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 000-23186 | Film No.: 18643948
SIC: 2836 Biological Products, (No Diagnostic Substances)